Advertisement
Screener

INOVIO PHARMACEUTICALS, INC. (INO) Income Tax Expense

2.8 / 5 stars · 68/120 Roast Me

INOVIO PHARMACEUTICALS, INC. Income Tax Expense

INOVIO PHARMACEUTICALS, INC. (INO) reported Income Tax Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2026-03-12

  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2020-12-31 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2020-09-30 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2020-06-30 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2020-03-31 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2025 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2024 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2023 was $0.00.
  • INOVIO PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 12 monthIncome Tax Expense (Benefit) 12 month as first filed
2025-12-31$0.00
10-K · filed 2026-03-12
2024-12-31$0.00
10-K · filed 2026-03-12
2023-12-31$0.00
10-K · filed 2026-03-12
2022-12-31$0.00
10-K · filed 2025-03-18
2021-12-31$0.00
10-K · filed 2024-03-06
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$0.00
derived: sum of 2 quarters · filed 2023-03-01
$0.00
derived: sum of 3 quarters · filed 2023-03-01
$0.00
10-K · filed 2023-03-01
2020-09-30$0.00
10-Q · filed 2020-11-09
$0.00
derived: sum of 2 quarters · filed 2020-11-09
$0.00
10-Q · filed 2020-11-09
-$87.76K
derived: sum of 4 quarters · filed 2021-03-01
2020-06-30$0.00
10-Q · filed 2020-08-10
$0.00
10-Q · filed 2020-08-10
-$87.76K
derived: sum of 3 quarters · filed 2021-03-01
-$87.76K
derived: sum of 4 quarters · filed 2021-03-01
2020-03-31$0.00
10-Q · filed 2020-05-11
-$87.76K
derived: sum of 2 quarters · filed 2021-03-01
-$87.76K
derived: sum of 3 quarters · filed 2021-03-01
-$194.53K
derived: sum of 4 quarters · filed 2021-03-01
2019-12-31-$87.76K
10-K · filed 2021-03-01
-$87.76K
derived: sum of 2 quarters · filed 2021-03-01
-$194.53K
derived: sum of 3 quarters · filed 2021-03-01
-$257.33K
10-K · filed 2022-03-01
2019-09-30$0.00
10-K · filed 2021-03-01
-$106.77K
derived: sum of 2 quarters · filed 2021-03-01
-$169.57K
10-Q · filed 2020-11-09
-$169.57K
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$106.77K
10-K · filed 2021-03-01
-$169.57K
10-Q · filed 2020-08-10
-$169.57K
derived: sum of 3 quarters · filed 2021-03-01
-$169.57K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$62.80K
10-K · filed 2021-03-01
-$62.80K
derived: sum of 2 quarters · filed 2021-03-01
-$62.80K
derived: sum of 3 quarters · filed 2021-03-01
-$62.80K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$0.00
10-K · filed 2020-03-12
$0.00
derived: sum of 2 quarters · filed 2020-03-12
$0.00
derived: sum of 3 quarters · filed 2020-03-12
$2.17M
10-K · filed 2021-03-01
2018-09-30$0.00
10-K · filed 2020-03-12
$0.00
derived: sum of 2 quarters · filed 2020-03-12
$2.17M
10-Q · filed 2019-11-12
$2.17M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30$0.00
10-K · filed 2020-03-12
$2.17M
10-Q · filed 2019-08-08
$2.17M
derived: sum of 3 quarters · filed 2020-03-12
$2.17M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$2.17M
10-K · filed 2020-03-12
$2.17M
derived: sum of 2 quarters · filed 2020-03-12
$2.17M
derived: sum of 3 quarters · filed 2020-03-12
$2.17M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$0.00
derived: sum of 2 quarters · filed 2020-03-12
$0.00
derived: sum of 3 quarters · filed 2020-03-12
$0.00
10-K · filed 2020-03-12
2017-09-30$0.00
10-Q · filed 2018-11-08
$0.00
derived: sum of 2 quarters · filed 2018-11-08
$0.00
10-Q · filed 2018-11-08
$0.00
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30$0.00
10-Q · filed 2018-08-07
$0.00
10-Q · filed 2018-08-07
$0.00
derived: sum of 3 quarters · filed 2019-03-12
$0.00
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31$0.00
10-Q · filed 2018-05-09
$0.00
derived: sum of 2 quarters · filed 2019-03-12
$0.00
derived: sum of 3 quarters · filed 2019-03-12
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$0.00
derived: sum of 2 quarters · filed 2019-03-12
$0.00
10-K · filed 2019-03-12
2016-09-30$0.00
10-Q · filed 2016-11-09
$0.00
10-Q · filed 2016-11-09
2015-12-31-$308.52K
10-K · filed 2017-03-15
-$2.10M
derived: sum of 2 quarters · filed 2017-03-15
-$2.10M
derived: sum of 3 quarters · filed 2017-03-15
-$2.10M
10-K · filed 2018-03-14
2015-09-30-$1.79M
10-K · filed 2017-03-15
-$1.79M
derived: sum of 2 quarters · filed 2017-03-15
-$1.79M
10-Q · filed 2016-11-09
-$1.79M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$0.00
10-K · filed 2017-03-15
$0.00
derived: sum of 2 quarters · filed 2017-03-15
$0.00
derived: sum of 3 quarters · filed 2017-03-15
$0.00
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31$0.00
10-K · filed 2017-03-15
$0.00
derived: sum of 2 quarters · filed 2017-03-15
$0.00
derived: sum of 3 quarters · filed 2017-03-15
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
$0.00
derived: sum of 2 quarters · filed 2017-03-15
$0.00
10-K · filed 2017-03-15
$29.00K
10-K · filed 2015-03-16
2014-09-30$0.00
10-Q · filed 2015-11-09
$0.00
10-Q · filed 2015-11-09
2013-12-31$0.00
10-K · filed 2016-03-14
$31.00K
10-K · filed 2014-03-17
2012-12-31$30.00K
10-K · filed 2015-03-16
2011-12-31$27.00K
10-K · filed 2014-03-17
2010-12-31$71.00K
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
MEDICINOVA INC (MNOV)United States$0.130B-6.04
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Immuneering Corp (IMRX)United States$0.113B-12.51